期刊文献+

人白细胞抗原交叉反应组配型在肾移植中的应用 被引量:2

Application of human leukocyte antigen and cross-reactive group matching in clinical renal transplantation
原文传递
导出
摘要 目的 探讨人白细胞抗原 (HLA)交叉反应组 (CREGs)配型原则在临床肾移植中的应用及意义。 方法  3 12例肾移植患者分为两组 ,一组按传统配型原则错配 2个以上位点并采用CREGs配型原则选择供受者 ,149例 ;另一组为同期按传统配型原则错配 0~ 2个位点者 ,163例。比较两组移植肾 1年存活率及术后 1个月内急性排斥发生率。 结果 按CREGs配型原则 ,供受者HLA Ⅰ类抗原 0、1、2错配百分比分别为 16.7%、41.6%和 3 4.2 % ,传统配型者分别为 6.7%、2 1.5 %和 71.8%。CREGs 0、1错配组相配率显著高于传统配型对应组 (P <0 .0 1)。术后 1个月急性排斥反应发生率各对应组间相比差异无显著性意义 (P >0 .0 5 ) ,但CREGs 0错配组明显低于A、B 2错配组 (P <0 .0 5 )。移植肾 1年存活率各对应组间差异无显著性意义 (P >0 .0 5 ) ,但CREGs 0错配组明显高于A、B 2错配组 (P <0 .0 5 )。 结论 采用CREGs配型原则选择供受者 ,可以获得满意的移植肾 1年存活率 ,并不增加术后排斥反应发生率 。 Objective To investigate the application and significance of human leukocyte antigen (HLA) and cross reactive groups(CREGs) matching in clinical renal transplantation. Methods A total of 312 cases of kidney transplantation were divided into two groups.In one group of 149 cases of kidney transplantations,ClassⅠCREGs matching criteria were applied instead of conventional HLA A,B matching which had two A,B mismatches(MM).In the other group of 163 cases of kidney transplantation there were A,B 0~2MM by the conventional criteria.The graft survival rate at 1 year and incidence of acute rejection within 1 month after transplantation were compared between the 2 groups. Results The percentages of HLA Ⅰ antigens 0,1,2MM were 16.7%,41.6% and 34.2% by CREGs matching criteria,and were 6.7 %,21.5% and 71.8% by conventional matching criteria.The matching rates in CREGs 0,1MM group were significantly higher than those in corresponding conventional matching group ( P <0.01).There were no significant differences in incidence of acute rejection at 1 month after transplantation between the corresponding groups ( P >0.05);however,the incidence rate of CREGs 0MM group was obviously lower than that of A,B 2MM group ( P < 0.05 ).The differences of 1 year graft survival rates between the corresponding groups were not statistically significant ( P > 0.05 ),but the rate of CREGs 0MM group was obviously higher than that of A,B 2MM group ( P <0.05). Conclusions Increased survival rate and reduced acute rejection can be achieved by CREGs matching criteria.Moreover, using CREGs matching criteria would significantly increase the chance of recipients to receive well matched kidneys.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2003年第3期160-162,共3页 Chinese Journal of Urology
关键词 肾移植 人白细胞抗原 交叉反应 移植物排斥 Kidney transplantation Human leukocyte antigen Cross reactive Graft rejection
  • 相关文献

同被引文献15

  • 1Thompson JS,Thacker LR. CREG Matching for first cadaveric kidney transplants(TNX)performed by SEOPE centers between 1987 and 1995[J].Clin Transplant,1996,10:586-593.
  • 2Gebel HM,Haris SB,Zibari G,et al.Conundrums with flow PRA beads[J].Clin Transplant,2002,16(Suppl 7):24-29.
  • 3Crow DO.The effect of cross-reactive epitope group matching on allocation and sensitization[J].Clin Transplant,2003,17(Supple19):13-16.
  • 4Takemoto S,Gjertson DW,Terasaki PI. HLA matching:a comparison of conventional and molecular approaches.In:Terasaki PI,Cecka JM,eds.Clinical transplants[J].Los Angeles:UCLA Tissue Typing Laboratory,1992,413-419.
  • 5Collins RW,Harmer AW,Heads AJ,et al.The clinical importance of variation within the HLA-Bw4 complex[J].Transplantation,2001,72:1851-1853.
  • 6Thompson JS,Thacker LR. CREG Matching for first cadaveric kidney transplants(TNX)performed by SEOPE centers between 1987 and 1995:An analysis of outcome and prospective benefit [J].Transplant-proc,1997,29:1435-1438.
  • 7Yvo WJS,Ilias IND,Johan Wde Fijter, et al.Shareing cross-reactive groups of MHC classⅠimproves lomg-term graft survival[J].Kindney International,1999,56:1920-1927.
  • 8Rose ML.Role of MHC and non-MHC alloantibodies in graft rejection[J].Curr Opin Organ Trsplant,2004,9:16-19.
  • 9Wu JY,Chen JH,Wang YM,et al.Improved clinical outcomes in Chinese renal allogrft recipients receiving lower dose immunosuppressants [J].transplantation, 2004,78(5):713-716.
  • 10McKenna RM,Lee kR,Gough JC,et al.Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function[J]. Transplantation, 1998,66:38-43.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部